ghb04l1
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2008 (NCT00741806)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ghb04l1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03745274 | Phase 1 | Dec 19, 2008 | AVIR Green Hills Biotechnology AG, Russian Academy of Medical Sciences |
| NCT00741806 | Phase 1 | Aug 1, 2008 | AVIR Green Hills Biotechnology AG, University of Vienna |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AVIR Green Hills Biotechnology AG | For profit | 2 | 2 | 1 | 2008 |
| Russian Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Vienna | Academic/Hospital | 1 | 0 | 1 | 2008 |
3 organizations
Page 1 / 1